Medication info
Rodistal Tablet 40/5 mg (Telmisartan, Amlodipine Besylate)

Rodistal Tablet 40/5 mg (Telmisartan, Amlodipine Besylate)

Prescription medicationOral
Ingredient · strength
Telmisartan Powder 23.9%›167.36mg / 1 tabletAmlodipine Besylate›6.935mg / 1 tablet
Manufacturer / importer
Medica Korea Co., Ltd.
Appearance
A white and light gray, double convex, oval-shaped tablet.
Packaging
For domestic use - 30 tablets/PTP [30 tablets (10 tablets/Alu-Alu X 3)]
Approval status
Active

MFDS item code 201901005 · Approved 2019.02.19 · Insurance code 646004630

Summary

Main use
Treatment of essential hypertension not controlled by monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this drug is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before starting this drug, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components as described below, a direct switch to this drug may be considered. - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this drug 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. Patients taking telmisartan and amlodipine concomitantly may switch to this drug (a fixed-dose combination with the same amount of each active ingredient) for convenience (limited to this drug 40/5 milligrams). ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to initiate treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine dosage is recommended for elderly patients, but caution should be exercised when increasing the dose. (See section ‘3. Patients requiring caution in administration’.) In elderly patients aged 75 years or older, amlodipine clearance is reduced; therefore, initiate treatment at a low dose and increase the dose gradually.
Child dose
Pediatric patients aged 18 years or younger: The safety and efficacy of this drug have not been established; therefore, its use is not recommended.

Ingredients

Manufacturer
Medica Korea Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled by monotherapy

  • Essential Hypertension
View approved original text

This medication is recommended for patients with essential hypertension whose blood pressure is not adequately controlled with either amlodipine or telmisartan alone. It aids in dilating blood vessels to reduce blood pressure and is effective in reducing the cardiovascular risks associated with hypertension. It plays a crucial role in the prevention of complications by managing essential hypertension reliably. Thus, it is used by individuals who require proper blood pressure control.

How to take

Adult dose

The recommended dose of this drug is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before starting this drug, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components as described below, a direct switch to this drug may be considered. - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this drug 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. Patients taking telmisartan and amlodipine concomitantly may switch to this drug (a fixed-dose combination with the same amount of each active ingredient) for convenience (limited to this drug 40/5 milligrams). ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to initiate treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine dosage is recommended for elderly patients, but caution should be exercised when increasing the dose. (See section ‘3. Patients requiring caution in administration’.) In elderly patients aged 75 years or older, amlodipine clearance is reduced; therefore, initiate treatment at a low dose and increase the dose gradually.

Child dose

Pediatric patients aged 18 years or younger: The safety and efficacy of this drug have not been established; therefore, its use is not recommended.

Precautions

This medication can cause serious side effects to the fetus or newborn, especially during the second and third trimesters of pregnancy; therefore, it should not be taken by pregnant women or women who may become pregnant. It should not be administered to patients with an allergy to this medication or similar drugs, nursing mothers, patients with obstructive biliary disease, severe liver impairment, or specific heart-related diseases. Particular care should be taken when using this medication in patients with primary aldosteronism, certain heart valve diseases, liver impairment, gastrointestinal diseases, renal vascular diseases, renal failure, and elderly individuals. Common side effects include dizziness and peripheral edema, and rarely, serious side effects like fainting or cardiac issues may occur. During pregnancy, use of this medication poses risks such as decreased renal function in the fetus, delayed skull formation, and renal failure in the newborn; therefore, use should be discontinued immediately upon confirmation of pregnancy, and consultation with a physician is necessary. As this medication lowers blood pressure, patients with hypotension or dehydration should manage their condition prior to taking it and should take it under a physician's guidance. There is a risk of elevated potassium levels, so patients at risk for hyperkalemia should have regular blood tests and careful monitoring. Patients with impaired kidney function should monitor their renal functionality regularly while taking this medication, and its safety in kidney transplant recipients has not been established. One of the components of this medication may increase the risk of angina or myocardial infarction in some heart disease patients, so caution is advised when taken by patients with heart diseases. This medication may cause drowsiness or dizziness; therefore, caution should be exercised when driving or operating heavy machinery while on this medication. Interactions may occur with other antihypertensives or specific medications, so inform the physician or pharmacist of any other medications being taken. Pregnant or nursing women should not take this medication, and consultation with a healthcare provider is necessary if there are plans for pregnancy or if pregnancy occurs. The safety and efficacy in pediatric patients have not been sufficiently established; therefore, it is advised that individuals under 18 years of age do not use this medication. Elderly patients may react more sensitively to this medication; therefore, dosages should be adjusted and managed carefully. In cases of overdose, the risk of severe hypotension and cardiac function decline exists; immediate medical attention is required.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory tract infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 102 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • mood changes
  • anxiety
  • confusion
  • drowsiness
  • headache
  • migraine
  • paresthesia
  • sensory loss
  • altered taste
  • tremor
  • extrapyramidal disorder
  • hypertonia
  • visual disturbances
  • diplopia
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • vasculitis
  • cough
  • dyspnea
  • rhinitis
  • changes in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • aerophagia
  • vomiting
  • dry mouth
  • gingival hyperplasia
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • liver dysfunction
  • liver impairment
  • hepatitis
  • jaundice
  • increased liver enzymes
  • pruritus
  • hyperhidrosis
  • rash
  • alopecia
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic skin rash
  • drug rash
  • urticaria
  • erythema multiforme
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • low back pain
  • limb pain
  • tendon pain
  • renal impairment
  • urinary disorders
  • frequency of urination
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • edema
  • asthenia
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • increased liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • increased blood uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a container that does not allow light to enter. To maintain the medication's efficacy, it is best stored at a temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

A white and light gray, double convex, oval-shaped tablet.

Package unit

For domestic use - 30 tablets/PTP [30 tablets (10 tablets/Alu-Alu X 3)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.